Close Menu

MTM Laboratories

Paired with Roche's HPV testing offerings, the deal will expand its cervical cancer testing capabilities.

The German-based company expects to file its test for FFPE within the next few months, and to start a clinical trial for its cytology test by mid-year.

The funds will be used to support clinical trials and commercialization efforts, as well as US regulatory clinical trials for a PMA submission for its CINtec Plus Cytology platform.

The CTAF recommendation is "an important decision-making resource for clinicians and patients," the firm's CEO said.

Patents awarded to GeneNews, US Army, Aisin Seiki, MTM Laboratories, and USC.

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.